Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
June 24th, 2020
3.1K views
This protocol describes the use of flow cytometry to identify the changes in immune cell composition, cytokine profile, and chemokine profile in the pulmonary environment following transient middle cerebral artery occlusion, a murine model of ischemic stroke.
Overview
This protocol describes the use of flow cytometry to investigate alterations in the pulmonary environment following ischemic stroke. It allows for the identification of various immune cell types and cytokines in a murine model.
Key Study Components
Area of Science
- Neuroscience
- Immunology
- Stroke Research
Background
- Transient middle cerebral artery occlusion is a murine model of ischemic stroke.
- Flow cytometry enables detailed analysis of immune responses.
- Understanding pulmonary changes can inform stroke recovery.
- This method can also be applied to allergic responses or infections.
Purpose of Study
- To identify changes in immune cell composition post-stroke.
- To assess cytokine and chemokine profiles in the pulmonary environment.
- To provide insights into the immune response following ischemic events.
Methods Used
- Flow cytometric analysis of lung immune cells.
- Identification of 13 immune cell types.
- Assessment of 13 different cytokines and chemokines.
- Whole body transcardial perfusion technique.
Main Results
- Alterations in immune cell types were observed post-stroke.
- Changes in cytokine and chemokine profiles were identified.
- The method proved effective for analyzing pulmonary responses.
- Potential applications extend to other immune challenges.
Conclusions
- Flow cytometry is a valuable tool for studying immune responses.
- Insights gained can enhance understanding of stroke recovery.
- This protocol can be adapted for various immunological studies.
Frequently Asked Questions
What is the main focus of this protocol?
The protocol focuses on using flow cytometry to analyze immune cell and cytokine changes in the pulmonary environment after ischemic stroke.
Can this method be used for other conditions?
Yes, it can also be applied to study allergic responses and infections.
How many immune cell types can be identified?
The method allows for the identification of 13 different lung immune cell types.
What are cytokines and chemokines?
Cytokines and chemokines are signaling molecules that mediate and regulate immunity and inflammation.
What is the significance of the pulmonary environment in stroke?
The pulmonary environment plays a crucial role in the immune response and recovery following ischemic stroke.
What is whole body transcardial perfusion?
It is a technique used to prepare the mouse for flow cytometric analysis by ensuring clear access to the pulmonary system.
Executive Industry Relevance
Comprehensive immune profiling of the pulmonary environment following ischemic stroke enables mechanistic de-risking and target validation for immunomodulatory strategies. Quantitative flow cytometric analysis of immune cell subsets and cytokine mediators supports predictive confidence in early discovery and translational research. This approach informs portfolio decisions by clarifying immune alterations relevant to post-stroke complications and other pulmonary disease models.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of immune cell dynamics and cytokine expression in disease-relevant pulmonary tissue.
- Supports functional target validation by quantifying 13 immune cell types and 13 cytokines/chemokines in parallel.
- Facilitates mechanistic de-risking for immunological hypotheses in stroke and pulmonary disease models.
- Provides predictive confidence for advancing immunomodulatory targets.
Screening & Assay Development
- Delivers standardized, reproducible immune cell and cytokine quantification using validated flow cytometry panels.
- Prepares high-quality single-cell suspensions suitable for downstream screening workflows.
- Enables multiplexed readouts for scalable assay development and compound evaluation.
- Supports platform reuse across diverse pulmonary and immunological research settings.
Translational & Preclinical Research
- Aligns immune profiling outputs with disease-relevant biomarkers for translational continuity.
- Enables risk-adjusted advancement decisions by quantifying immune perturbations post-stroke or in infection/allergy models.
- Supports preclinical model validation through robust, quantitative immune readouts.
- Facilitates cross-study comparisons of immune modulation strategies.
Pipeline & Workflow Integration
This method integrates into the discovery-to-preclinical continuum by enabling quantitative immune profiling from early hypothesis testing through translational validation.
- Discovery Biology: Supports hypothesis testing and pathway clarification by mapping immune cell and cytokine changes in the lung.
- Screening: Provides reproducible, quantitative outputs for immune cell and mediator assays.
- Analytics: Delivers multiplexed measurements for comparative analysis of experimental conditions.
- Translational Research: Connects immune alterations to disease-relevant endpoints in preclinical models.
- Enterprise Reuse: Offers a reusable immune profiling platform adaptable to multiple pulmonary disease contexts.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in immune-targeted research.
- Operational Value: Standardizes immune cell and cytokine quantification for reproducibility and scalability.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency by clarifying immune mechanisms.
- Portfolio Impact: Enables risk-adjusted prioritization of immunomodulatory programs targeting pulmonary complications.
Implementation Considerations
- Requires expertise in multicolor flow cytometry and immune cell marker selection.
- Needs access to bead-based homogenization and multiplex flow cytometric instrumentation.
- Demands cross-team standardization of tissue processing and antibody panels.
- Adaptable to various murine pulmonary disease models with protocol optimization.
- Cell recovery and cytokine quantification are sensitive to enzymatic dissociation parameters.
Biopharma FAQs
Why does null hypothesis testing matter for immune cell quantification?
Null hypothesis testing ensures that observed changes in immune cell populations and cytokine levels post-stroke are statistically significant, supporting robust target validation and reducing false positives in early discovery.
How does independent variable isolation fit multiplex cytokine analysis?
Isolating variables such as stroke induction or infection allows multiplex bead arrays to attribute cytokine changes specifically to experimental conditions, strengthening mechanistic insights and discovery pipeline rigor.
What do quantitative dependent variable measurements enable in flow cytometry?
Quantitative measurement of immune cell subsets and cytokine concentrations enables direct comparison across experimental groups, facilitating data-driven decisions for target prioritization and assay development.
Why are replication requirements critical for lung immune profiling?
Replication ensures that immune cell and cytokine findings are reproducible across experiments and teams, supporting cross-functional collaboration and enterprise-wide data reliability.
What statistical analysis capabilities are required before implementing multiplex flow cytometry?
Robust statistical analysis is needed to interpret multiplex flow cytometry data, including significance testing and normalization, to ensure reliable conclusions for R&D decision-making.
Chapters in this video
0:04
Introduction
0:45
Lung Tissue Harvest
2:50
Lung Tissue Homogenization
3:44
Lung Tissue Dissociation and Single Cell Isolation
5:21
Flow Cytometric Lung Immune Cell Niche Analysis
6:27
Results: Representative Immune Cell Population and Chemokine Expression Characterization
8:35
Conclusion
